Sintx Technologies, Inc. (SINT): Capital Expenditures
$185.0K
Year ended 2025-12-31
$217.0K
Trailing 12 months to 2026-06-30
-49.1%
3-year compound annual growth
-12.5%
5-year compound annual growth
-12.4%
10-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $185.0K | -73.2% | 2026-03-20, From 2025-01-01 |
| 2024-12-31 | $690.0K | +30.2% | 2026-03-20, From 2024-01-01 |
| 2023-12-31 | $530.0K | -62.3% | 2025-03-19, From 2023-01-01 |
| 2022-12-31 | $1.41M | -62.5% | 2024-03-27, From 2022-01-01 |
| 2021-12-31 | $3.74M | +940.0% | 2023-03-29, From 2021-01-01 |
| 2020-12-31 | $360.0K | +144.9% | 2022-03-25, From 2020-01-01 |
| 2019-12-31 | $147.0K | n/m | 2021-03-22, From 2019-01-01 |
| 2018-12-31 | $11.0K | +83.3% | 2020-03-26, From 2018-01-01 |
| 2017-12-31 | $6.0K | -99.1% | 2019-03-11, From 2017-01-01 |
| 2016-12-31 | $671.0K | -3.5% | 2018-03-29, From 2016-01-01 |
| 2015-12-31 | $695.0K | -68.0% | 2017-12-27, From 2015-01-01 |
| 2014-12-31 | $2.17M | -6.9% | 2016-03-23, From 2014-01-01 |
| 2013-12-31 | $2.33M | n/a | 2015-03-24, From 2013-01-01 |
Capital Expenditures at similar companies
| Company | Year ended | Capital Expenditures | Change YoY |
|---|---|---|---|
| Sintx Technologies, Inc. (SINT) | 2025-12-31 | $185.0K | -73.2% |
| RenovoRx, Inc. (RNXT) | 2025-12-31 | $2.0K | -83.3% |
| PetVivo Holdings, Inc. (PETV) | 2026-03-31 | $7.7K | -87.8% |
| Catheter Precision, Inc. (VTAK) | 2025-12-31 | $17.0K | -74.6% |
| Harvard Apparatus Regenerative Technology, Inc. (HRGN) | 2024-12-31 | $0 | -100.0% |
| EBR Systems, Inc. (NONE.) | 2025-12-31 | $3.68M | n/m |
| Co-Diagnostics, Inc. (CODX) | 2025-12-31 | $700.0K | -6.5% |
| Vycor Medical Inc (VYCO) | 2025-12-31 | $5.2K | -2.6% |
| Femasys Inc (FEMY) | 2025-12-31 | $525.0K | -31.1% |
Compare SINT, RNXT, PETV, VTAK side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗